These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 16878155

  • 1. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A, Zoltan-Jones A, Strizzi L, Bargo S, Kimura K, Salomon D, Callahan R.
    Oncogene; 2007 Feb 01; 26(5):662-72. PubMed ID: 16878155
    [Abstract] [Full Text] [Related]

  • 2. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH.
    Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493
    [Abstract] [Full Text] [Related]

  • 3. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L.
    Cancer Res; 2005 Mar 01; 65(5):1897-903. PubMed ID: 15753388
    [Abstract] [Full Text] [Related]

  • 4. Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).
    Raafat A, Bargo S, Anver MR, Callahan R.
    Oncogene; 2004 Dec 16; 23(58):9401-7. PubMed ID: 15531924
    [Abstract] [Full Text] [Related]

  • 5. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.
    Irsan I, Akisue T, Hara H, Fujimoto T, Imabori M, Doita M, Kuroda R, Fujioka H, Kawamoto T, Yamamoto T, Kurosaka M.
    Anticancer Res; 2007 Dec 16; 27(1A):423-9. PubMed ID: 17352263
    [Abstract] [Full Text] [Related]

  • 6. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.
    Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, Buono K, Salomon D, Vonderhaar BK, Callahan R.
    Oncogene; 2009 Jan 15; 28(2):219-30. PubMed ID: 18836481
    [Abstract] [Full Text] [Related]

  • 7. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP, Matthews KS, Kimball KJ, Conner MG, Baker AC, Barnes MN.
    Reprod Sci; 2008 Sep 15; 15(7):673-7. PubMed ID: 18492696
    [Abstract] [Full Text] [Related]

  • 8. Original Research: Featured Article: Imatinib mesylate (Gleevec) inhibits Notch and c-Myc signaling: Five-day treatment permanently rescues mammary development.
    Callahan R, Chestnut BA, Raafat A.
    Exp Biol Med (Maywood); 2017 Jan 15; 242(1):53-67. PubMed ID: 27550925
    [Abstract] [Full Text] [Related]

  • 9. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec).
    Ivan D, Niveiro M, Diwan AH, Eton O, Kim KB, Lacey C, Gonzalez C, Prieto VG.
    J Cutan Pathol; 2006 Apr 15; 33(4):280-5. PubMed ID: 16630177
    [Abstract] [Full Text] [Related]

  • 10. Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development.
    Smith GH, Gallahan D, Diella F, Jhappan C, Merlino G, Callahan R.
    Cell Growth Differ; 1995 May 15; 6(5):563-77. PubMed ID: 7544153
    [Abstract] [Full Text] [Related]

  • 11. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
    Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM.
    Cancer; 2003 Aug 15; 98(4):758-64. PubMed ID: 12910520
    [Abstract] [Full Text] [Related]

  • 12. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH.
    Gynecol Oncol; 2004 Oct 15; 95(1):32-6. PubMed ID: 15385107
    [Abstract] [Full Text] [Related]

  • 13. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4).
    Gallahan D, Callahan R.
    Oncogene; 1997 Apr 24; 14(16):1883-90. PubMed ID: 9150355
    [Abstract] [Full Text] [Related]

  • 14. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate).
    Mukherjee J, Kamnasaran D, Balasubramaniam A, Radovanovic I, Zadeh G, Kiehl TR, Guha A.
    Cancer Res; 2009 Jun 15; 69(12):5099-107. PubMed ID: 19509233
    [Abstract] [Full Text] [Related]

  • 15. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.
    Zhu MJ, Ou WB, Fletcher CD, Cohen PS, Demetri GD, Fletcher JA.
    Oncogene; 2007 Sep 27; 26(44):6386-95. PubMed ID: 17452978
    [Abstract] [Full Text] [Related]

  • 16. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK, Park YK.
    Pathol Res Pract; 2007 Sep 27; 203(3):127-34. PubMed ID: 17298867
    [Abstract] [Full Text] [Related]

  • 17. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP, Chen YY, Chen W, Howell SB, Shively JE, Alberts DS.
    Hum Pathol; 2005 Mar 27; 36(3):242-9. PubMed ID: 15791568
    [Abstract] [Full Text] [Related]

  • 18. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW, Wagner KU, Hennighausen L.
    Oncogene; 2001 Oct 25; 20(48):7115-9. PubMed ID: 11704837
    [Abstract] [Full Text] [Related]

  • 19. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J, Lopez JP, Altuna X, Chu TS, Weisman RA, Ongkeko WM.
    Laryngoscope; 2006 Aug 25; 116(8):1409-16. PubMed ID: 16885745
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of STI571 on cell proliferation of human malignant fibrous histiocytoma cell lines.
    Kawamoto T, Akisue T, Marui T, Nakatani T, Hitora T, Fujita I, Kurosaka M, Yamamoto T.
    Anticancer Res; 2004 Aug 25; 24(5A):2675-9. PubMed ID: 15517872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.